Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Edgewell Personal Care Company filings document the financial reporting, governance and capital-structure disclosures of a Missouri-incorporated personal-care company whose common stock trades on the New York Stock Exchange under EPC. Current Reports on Form 8-K furnish quarterly and fiscal-year operating results, non-GAAP earnings materials and Regulation FD updates.
The filing record also covers completed asset-disposition disclosures for the sale of the Feminine Care segment and transition services arrangements related to that transaction. Proxy materials document annual meeting matters, director and executive compensation governance, shareholder voting items and approval of the amended and restated 2018 Stock Incentive Plan.
Edgewell Personal Care Company director Rakesh Sachdev reported an equity award in the form of derivative securities. On February 5, 2026, he received 7,817 restricted stock equivalents at a price of $0 per unit, all held as a direct ownership position.
According to the filing, these restricted stock equivalents are designed to convert into the same number of shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Sachdev elects to defer conversion until his service on the Board of Directors ends. After this transaction, he beneficially owns 7,817 derivative securities tied to Edgewell common stock.
Edgewell Personal Care director Stephanie Stahl reported a new equity grant. On February 5, 2026, she acquired 7,817 restricted stock equivalents at a price of $0 per unit. These are derivative securities that track the value of Edgewell common stock.
The restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders, unless Stahl elects to defer conversion until her service on Edgewell’s Board of Directors ends. After this grant, she beneficially owned 7,817 derivative units directly.
Edgewell Personal Care Company director receives equity grant. Director John C. Hunter III was granted 7,817 restricted stock equivalents of Edgewell common stock at a price of $0 on 02/05/2026. These restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless he elects to defer conversion until his service on the Board ends.
Edgewell Personal Care Company director Corbin George reported receiving 7,817 restricted stock equivalents on February 5, 2026. These derivative securities were acquired at a price of $0 and are held as direct ownership.
According to the filing, the restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders, unless the director elects to defer conversion until service on the Board ends.
Edgewell Personal Care Company director equity grant
Edgewell Personal Care Company reported that director Gary Waring received an award of 7,817 restricted stock equivalents on February 5, 2026. These derivative securities were granted at a price of $0 per unit and are held in his direct ownership.
The restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Waring elects to defer conversion until his service on Edgewell’s Board of Directors ends. After this grant, he beneficially owns 7,817 restricted stock equivalents.
Edgewell Personal Care director Carla C. Hendra received 7,817 restricted stock equivalents on February 5, 2026. These derivative awards carry a stated price of $0 per unit and are held directly. They are designed to convert into shares of Edgewell common stock on a future date.
The restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless the director chooses to defer conversion until service on the Board of Directors ends. After this grant, 7,817 derivative securities are beneficially owned.
Edgewell Personal Care Company director receives equity award. Director Robert William Black was granted 7,817 restricted stock equivalents on February 5, 2026 at a price of $0 per unit. Following this grant, he beneficially owns 7,817 derivative securities directly.
The restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholder meeting, unless Black elects to defer conversion until his Board service ends.
Edgewell Personal Care Company reported first quarter fiscal 2026 results from continuing operations with net sales of $422.8 million, up 1.9% year over year, while GAAP diluted EPS was a loss of $(0.63) and adjusted EPS was $(0.16). Adjusted EBITDA from continuing operations was $25.0 million, down from $30.9 million a year earlier, as gross margin and operating margin compressed despite currency tailwinds and productivity savings.
The company completed the divestiture of its Feminine Care business for $340 million, now reported as discontinued operations, and ended the quarter with $223.3 million in cash and an adjusted net debt leverage ratio of 3.8x. Full‑year 2026 guidance for continuing operations keeps the prior outlook ranges, with reported net sales expected to grow about 0.5%–3.5%, GAAP EPS of $0.55–$0.95, adjusted EPS of $1.70–$2.10, and adjusted EBITDA of $245–$265 million, while restructuring charges are projected at approximately $65 million. Shareholders approved the 3rd Amended and Restated 2018 Stock Incentive Plan, adding 2,100,000 authorized shares for equity awards, and the board declared a quarterly dividend of $0.15 per share.
Edgewell Personal Care Company has completed the sale of its Feminine Care segment, including the Playtex, Stayfree, Carefree and o.b. brands, to Essity for $340 million in cash, subject to customary post‑closing adjustments. Edgewell plans to use the net proceeds, after taxes and transaction costs, primarily to strengthen its balance sheet by repaying its U.S. revolving credit facility and to continue investing in its core shave, sun and skin care, and grooming businesses.
At closing, Edgewell repaid $140 million outstanding on its revolving credit facility in the pro forma balance sheet, reducing long‑term debt. The company entered into a Transition Services Agreement to provide support services for at least one year, with options for Essity to extend certain services by three to six months. The Feminine Care business is treated as a discontinued operation, and Edgewell has provided unaudited pro forma financial information. On this basis, for the year ended September 30, 2025, net sales from continuing operations were $1,962.0 million and net earnings from continuing operations were $72.0 million, or $1.51 per diluted share, compared with historical continuing net earnings of $25.4 million, or $0.53 per diluted share.
Dimensional Fund Advisors LP reports beneficial ownership of 2,615,057 shares of Edgewell Personal Care Co common stock, representing 5.6% of the class as of 12/31/2025. Dimensional has sole power to vote 2,544,917 of these shares and sole power to dispose of 2,615,057 shares.
The shares are owned by various investment funds and accounts advised or sub-advised by Dimensional and its subsidiaries, and Dimensional disclaims beneficial ownership, stating the securities are held for the Funds. The filing also certifies that the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Edgewell Personal Care.